They found that TWIST1 expression predicts poor clinical outcomes in patients with clear cell carcinoma (CCC) of the ovary, suggesting that TWIST1 may play a critical role in the progression of CCC. Here, TWIST1 is linked to clear cell adenocarcinoma.